RT @BartoszHudzik: #Anticoagulation ➡️ #Mortality ⬇️⬇️ in Hospitalized Patients With #COVID19 👉 https://t.co/d3mpcvWjDT @JACCJournals @mma…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @HanCardiomd: AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared with prophylactic AC,…
RT @HanCardiomd: AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared with prophylactic AC,…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared with prophylactic AC, therapeutic AC was associated with lower mortality, although not statistically significant https://t.co/lm8Uoja5r4 @JACCJournals @mma
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19 https://t.co/Z2nVoXOJNm
RT @novitskiynic: Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With #COVID19: 📍AC associated ⤵️ mortality a…
RT @BartoszHudzik: #Anticoagulation ➡️ #Mortality ⬇️⬇️ in Hospitalized Patients With #COVID19 👉 https://t.co/d3mpcvWjDT @JACCJournals @mma…
RT @novitskiynic: Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With #COVID19: 📍AC associated ⤵️ mortality a…
RT @novitskiynic: Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With #COVID19: 📍AC associated ⤵️ mortality a…
RT @novitskiynic: Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With #COVID19: 📍AC associated ⤵️ mortality a…
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With #COVID19: 📍AC associated ⤵️ mortality and intubation among hospitalized pts 📍no difference between therapeutic vs prophylactic AC We give AC to all pts in 🏥 📎 https://t.co/
#Anticoagulation ➡️ #Mortality ⬇️⬇️ in Hospitalized Patients With #COVID19 👉 https://t.co/d3mpcvWjDT @JACCJournals @mmamas1973 @CMichaelGibson @JGrapsa @SABOURETCardio @HanCardiomd @AnastasiaSMihai @ALEX_MISCHIE https://t.co/ccUFXmPNSp
RT @gonzaeperez: ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisAC…
2/2 @JACCJournals -Análisis retrospectivo -Características basales (más comorbilidades y mayor elevación de biomarcadores grupo ACO y profACO) -ACO menos de 48hs⏩ noACO -Gran estudio pero ¿nos alcanza para cambiar la conducta? -Es necesario un RCT https
ANTICOAGULACIÓN, SANGRADO Y MUERTE EN PAC #COVID19 4389p NYC 🏥COVID19 retrospectivo -34% NoACO, 20% ACO y 44% ProfilaxisACO -ACO/ProfACO ⬇️💀e intubación 🆚noACO -Sin diferencias ACO 🆚profACO -26 Autopsias ⏩42% enf.tromboembolica no dx @JACCJournals 1/2 http
Anti-coagulation in hospitalised patients with COVID-19 Associated with lower mortality. Autopsy showed (42%) had thromboembolic disease not clinically suspected. https://t.co/fKUkhmuCZV https://t.co/lx7ZTYfmF9
RT @VPrasadMDMPH: I would have loved to publish this in the COVID issue of my new journal: The Journal of Observational Studies that Twart…
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study. By @girish_nadkarni @IcahnMountSinai @CNIC_CARDIO @CoVDataCenter @HPI_NYC @DOMSinaiNYC et al. in @JACCJournals https://t.co/JzlUKgAn
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study | JACC: Journal of the American College of Cardiology. Read this @Richardkcheng2 https://t.co/HAQUjMhgCv
@DocPaf Exactement ce que je disais là https://t.co/uyVy4ho8j2
RT @kitkaym: Blood thinneers are going for COVID-19 clinical trials. https://t.co/e94UOMJSEI #anticoagulant #heparin #eliquis #covid19 #m…
Blood thinneers are going for COVID-19 clinical trials. https://t.co/e94UOMJSEI #anticoagulant #heparin #eliquis #covid19 #medicinalchemistry #pharmaceuticalchemistry #drugdiscovery #drugdesign #drugdevelopment #imu #sarscov2 https://t.co/BCCpyCPDhv
This study adds to retrospective data supporting a prothrombotic coagulopathy in COVID-19 patients that benefits from anticiagulation, although additional studies are needed to compare various strategies...LOLTA
A retrospective study of hospitalised patients with COVID-19 in NYC showed that therapeutic anticiagulation was associated with lower mortality and intubation. Recently published in JACC...LOLTA https://t.co/CKoPx3G9pX
RT @almoskow: I might be late to the game on this, but came across the below new publication in @JACCJournals on anticoagulation for #COVID…
I might be late to the game on this, but came across the below new publication in @JACCJournals on anticoagulation for #COVID-19. https://t.co/jyyncOpKib This is a follow-up study that builds on the original letter published in June 2020. https://t.co/
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
I think we took this one apart already. https://t.co/qTlqRXA7af @WalkeyAllan @ADAlthousePhD
RT @atscommunity: Anticoagulation, mortality, bleeding and pathology among patients hospitalized with #COVID19: A single health system stud…
RT @atscommunity: Anticoagulation, mortality, bleeding and pathology among patients hospitalized with #COVID19: A single health system stud…
Anticoagulation, mortality, bleeding and pathology among patients hospitalized with #COVID19: A single health system study: https://t.co/RJRWjAir1q
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/aOq8BnnMPF
RT @zambo57: Finally therapeutic dose of LMWH-NOAC reduces mortality and intubation from #COVIDー19 https://t.co/ey8PDsvxh9
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @horstie: Observational data on grade of #anticoagulation in #covid19 from one health system. I wonder why you would use no anticoagul…
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
Observational data on grade of #anticoagulation in #covid19 from one health system. I wonder why you would use no anticoagulants. Looking forward to an #RCT answering the question what is best (and when)... https://t.co/InS81OEdTG @NATAforum
RT @FZores: Vient d'être publiée dans le JACC une étude sur COVID19 et anticoagulation. https://t.co/WxVrERtuW8 (derrière un paywall, la m…
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study. . . En conclusión: al menos tromboprofilaxis farmacológica en las primeras 48 Hr. Luego nos podremos de acuerdo respecto a NOACs. h
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados https://t.co/7jSgzI…
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados https://t.co/7jSgzI…
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
RT @LuisZuritaG: Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
Anticoagulacion profiláctica o terapéutica en COVID, disminuye mortalidad en 50 % vs no anticoagulados
Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hosp... https://t.co/eA5EcXORaj
@FZores Via PubMed, le paywall saute https://t.co/xkdyToDkBB
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
@FZores https://t.co/wPNs4TBr1y Free version. No supplemental. Here is the trick: "those patients treated with both therapeutic and prophylactic regimens of AC during their hospitalization were excluded"
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @FZores: Vient d'être publiée dans le JACC une étude sur COVID19 et anticoagulation. https://t.co/WxVrERtuW8 (derrière un paywall, la m…
Vient d'être publiée dans le JACC une étude sur COVID19 et anticoagulation. https://t.co/WxVrERtuW8 (derrière un paywall, la mise à disposition gracieuse des études COVID semble révolue) C'est ENCORE une étude de cohorte rétrospective.
RT @doctormacias: Anticoagulación y mortalidad: la anticoagulación se asocia con una reducción de la mortalidad hospitalaria entre los paci…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @VPrasadMDMPH: I would have loved to publish this in the COVID issue of my new journal: The Journal of Observational Studies that Twart…
RT @pmorenofranco: AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared to prophylactic AC,…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
AC was associated with lower mortality and intubation among hospitalized COVID-19 patients. Compared to prophylactic AC, therapeutic AC was associated with lower mortality, though not statistically significant. https://t.co/PUQ8gmRAgW @Dev_Sanghavi @ErbenY
RT @VPrasadMDMPH: I would have loved to publish this in the COVID issue of my new journal: The Journal of Observational Studies that Twart…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…
RT @ProfMakris: Huge (n=4389)observational study from New York in patients admitted with #COVID19, comparing full, prophylactic and no anti…